Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
Pediatr Pulmonol. 2002 Oct;34(4):287-96. doi: 10.1002/ppul.10162.
Pediatr Pulmonol. 2002.
PMID: 12205570
Clinical Trial.
Tolerability was evaluated by changes in vital signs and adverse events.Thirty-six out of 44 patients enrolled finished the short-term treatment period, and 19 out of 23 who continued the study also finished the long-term treatment period. ...Also, there were more a …
Tolerability was evaluated by changes in vital signs and adverse events.Thirty-six out of 44 patients enrolled finished the short-term …
A longitudinal study of bronchodilator responsiveness in cystic fibrosis.
Hordvik NL, König P, Morris D, Kreutz C, Barbero GJ.
Hordvik NL, et al.
Am Rev Respir Dis. 1985 Jun;131(6):889-93. doi: 10.1164/arrd.1985.131.6.889.
Am Rev Respir Dis. 1985.
PMID: 4003942
All but 1 subject (95%) showed a significant bronchodilator response at least once on an outpatient basis; nonhospitalized subjects were responsive 49% of the time. Bronchodilator responsiveness was unrelated to long-term pulmonary severity or indexes of atopy but it was s …
All but 1 subject (95%) showed a significant bronchodilator response at least once on an outpatient basis; nonhospitalized subjects were res …
Item in Clipboard
Cite
Cite